Roles of an immune-check point inhibitor (nivolumab) in heavily pretreated and platinum-resistant gynecologic cancers

Autor:	Yoshihiro Kikuchi, Hiroko Kouta, Masashi Takano, Takayoshi Asakawa, Miyuki Horikoshi, Tomoyuki Yoshikawa, Kenichi Furuya
Rok vydání:	2018
Předmět:	Oncology Cancer Research medicine.medical_specialty Chemotherapy endocrine system diseases business.industry medicine.medical_treatment female genital diseases and pregnancy complications Immune system Internal medicine Medicine Nivolumab business Check point Platinum resistant
Zdroj:	Journal of Clinical Oncology. 36:e17562-e17562
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2018.36.15_suppl.e17562
Popis:	e17562Background: Although most of gynecologic cancers receive platinum-containing chemotherapy after the first surgical procedure, the most cases eventually relapse and develop to platinum-resista...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::027efd59de131c58f38f2a27060680ef https://doi.org/10.1200/jco.2018.36.15_suppl.e17562 Zobrazit plný text záznamu